AQST — Aquestive Therapeutics Share News
0.000.00%
Last trade - 00:00- $507.07m
- $549.32m
- $44.55m
Aquestive Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm Sublingual Film
Aquestive Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Estée Lauder, Quanta Services
Aquestive Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Inc Reports Positive Topline Data From Temperature / pH Study Of Anaphylm™ (Epinephrine) Sublingual Film
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Receives U.S. FDA Approval And Market Access For Libervant Buccal Film In Pediatric Patients Ages 2 To 5
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Airbnb, Albemarle, Biogen
Brief: Aquestive Therapeutics Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing
Brief: Aquestive Therapeutics Strengthens Board Of Directors With Experienced Biotech Executive
Brief: Aquestive Therapeutics Closes Underwritten Public Offering
U.S. STOCKS ON THE MOVE-Enservco, Citigroup, Tencent
U.S. STOCKS ON THE MOVE-J.Jill, LivaNova, International Paper
U.S. STOCKS ON THE MOVE-PDD, Best Buy, Nasdaq
Aquestive Therapeutics drops on $75 mln stock offering